Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: SpanyolországFázis nélkül

Telematic Intervention for Reversing Frailty Among Older Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Intervention. the TELE-FRAIL TAVI Clinical Trial

A legfontosabb adatok

Ki végzi
Spanish Society of Cardiology
Hol
Madrid (Spanyolország)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
206 fő, tervezett
Kezdés
2025. jan.
Tervezett befejezés
2025. dec.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
A vizsgált kezelések
  • Telematic intervention
A regiszteradat frissítve
2024. december 19.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for frail older people with aortic stenosis (a narrowed heart valve) who are having TAVI, a valve replacement through a catheter.

Életkor
75 Years or older
Nem
All sexes
A betegség stádiuma
Severe aortic stenosis with symptoms. People must also be frail, with a Short Physical Performance Battery (SPPB) score below 10.
Korábbi kezelés
People must be having TAVI. The summary says the TAVI must have been successful during the hospital stay.
Biomarker vagy leletérték
SPPB score <10. The summary also names a FRAIL scale value ≥3, a mean aortic gradient ≥40 mmHg and/or an aortic valve area < 1cm2 on heart ultrasound.

A részvétel fő kizáró okai

  • Not able to sign informed consent
  • Not able to complete a full geriatric assessment
  • Not able to complete follow-up visits
  • Expected to live less than one year (stated in the summary)

A regiszter feltételei, szó szerint

Mind a 5 feltétel megnézéseKevesebb

Ki vehet részt

  • older patients with aortic stenosis undergoing TAVI
  • baseline frailty criteria (SPPB <10)

Ki nem vehet részt

  • unability to sign informed consent
  • unability to complete geriatric assessment
  • unability to complete follow up

Helyszínek itt: Spanyolország

  • Calle de Nuestra Señora de Guadalupe, Nº 5 y 7 28028, Madrid (España)Madrid, SpanyolországContact: Blanca Miranda Serrano BMS Dr, MDToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

The TELE FRAIL clinical trial is a randomized trial designed to compare, among older frail patients with aortic stenosis undergoing transcatheter valve intervention (TAVI), the impact of usual care after vs a telematic intervention (including a supervised exercise training program, nutrition and education) on frailty reversal and clinical outcomes three months after the TAVI procedure.

A teljes eredeti leírásKevesebb

The trial will include older patients a with baseline frailty criteria with severe AS undergoing TAVI. A comprehensive geriatric assessment will be performed after the TAVI procedure in all patients.

Inclusion criteria will be: a) patients aged 75 years or older; b) severe symptomatic aortic stenosis, as defined by a mean aortic gradient≥40 mmHg and/or an aortic valve area < 1cm2 measured by transtoracic echocardiography; c) performance of successful TAVI during the admission, and d) baseline frailty criteria, as defined by Short Physical Performance Battery test value <10 and a FRAIL scale value ≥3.

Exclusion criteria will be: a) negative to participate in the trial; b) unability to undergo a comprehensive geriatric assessment or study related procedures ; c) unability to complete clinical follow up, and d) life expectancy lower than one year.

Patients will be randomized (1:1) to intervention or control arms before hospital discharge after the TAVI procedure.

Patients assigned to the intervention will undergo a telematic intervention during the first 90 days after the admission. Trained nurses form an specialized company will contact patients by videocalls at weeks 1,3,5,7,9,11 an12 months. This telematic intervention will include 1) a supervised exercise program (based on an adaptation of the VIVI-FRAIL program) during this 12 weeks; 2) nutrition intervention: The investigator team will provide patients with nutrition supplements for the first 12 weeks after the admission. Patients will take daily a dose of 200 ml of hypercaloric hyperproteic supplements one hour after performing the corresponding exercise training session. Patients will also receive information about the optimal dieta adapted to their clinical profile; and c) health education about the disease, the importance of adherence to medical treatments and recommendations and the best measures for preventing complications.

Main outcome measured will be the proportion of patients with frailty (as measured by a Short Physical Performance Battery test value <10) 3 months after the admission.

Secondary outcomes will include 1) the number of days alive out of hospital during the first year, 2) need for readmission at 3 months and at one year, 3) overall mortality at one year, 4) incidence of cardiovascular events (myocardial infarction, need for unplanned revascularization or stroke) at 3 months and at one year, 5) proportion of frail patients (SPPB<10) at one year, 6)disability for acitivies of daily living (Barthel index) at three months and at one year, 7) nutritional risk (as measured by the MA-Sf test) at three months and at one year and 8) quality of life (as defined by the EQ-5D-5L test) at three months and at one year.

A vizsgálat 2 csoportja

  • Usual care after TAVINincs vizsgálati kezelés, összehasonlításként

    3 months usual care after TAVI

  • Telematic interventionA vizsgált kezelés

    Telematic intervention will be performed by a specialized company hired by the investigational team. Trained nurses will contact patients assigned to the intervention groups by videocalls at weeks 1,3,5,7,9,11 and 12 after the admission. The specialized nurses will supervise the exercise program sessions (based on an adaptation of he VIVI FRAIL program), correcting potential mistakes and recommending the optimal way for performing the training program. Patients will take a 200 ml dose of hyperproteic, hypercaloric nutrition supplements daily one hour after performing the exercise session. Information about the optimal diet adapted to the clinical profile of patients will be also provided. Additionally, health information about the disease, the importance of adherence to treatments and recommendations and the best measures for controling cardiovascular risk factors, comorbidities and avoiding clinical complications will be also provided

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Impact of a Telematic Intervention Based on Exercise, Nutrition and Education on Frailty Reversion and Prognosis Among Older Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Intervention: the TELE-FRAIL TAVI Clinical Trial
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Publikációk
A regiszteradat frissítve
2024. december 19.